|
 |
|
|
|||
|
 |
|
Nov. 12, 2026 Source: Corteva news release INDIANAPOLIS, IN -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the third quarter and nine months ended September 30, 2026. 2026 YTD Highlights *Net sales decreased 1% and organic1 sales decreased 4%. Volume was flat with growth in all regions, except Latin America. Price declined 4%, primarily reflecting pressure on molecules late in their lifecycle in Brazil and acetochlor in the U.S. *Pro Forma GAAP income from continuing operations after taxes was $112 million, with a margin of 2.1%, while earnings per share (EPS) from continuing operations was $0.16 per share. *Adjusted Pro Forma Operating EBITDA1 and Operating EPS1 were $943 million, and $0.76 per share, respectively. Adjusted Pro Forma Operating EBITDA margin expanded 30 basis points to 17.6%. *Board of Directors authorized first common dividend post spin. *Company updates full-year 2026 guidance3 and expects Adjusted Pro Forma Operating EBITDA1 to be in the range of $1.1 to $1.125 billion. Adjusted Pro Forma Operating EPS1 is expected to be between $0.76 and $0.80 per share. 2026 Guidance Agricultural fundamentals continue to be supported by the need for growers to improve productivity and protect yield, driving demand for differentiated technologies. However, Crop Protection market conditions have become more challenging, particularly in Brazil, where farmer liquidity constraints, elevated financing costs, just-in-time purchasing and increased pricing pressure have resulted in a significantly softer market than previously anticipated. Demand for the Company's differentiated new products remains strong, and regional performance outside Latin America has been resilient. Reflecting these market dynamics, primarily the deterioration in Brazil, the Company updated its full-year 2026 guidance³. Adjusted Pro Forma Operating EBITDA¹ is now expected to be between $1.1 billion and $1.125 billion, and Adjusted Pro Forma Operating EPS1 is expected to be between $0.76 and $0.80 per share. The Company remains focused on the priorities within its control, including differentiated innovation, productivity and disciplined execution. The Company is not able to reconcile its forward-looking non-GAAP financial measures to its most comparable U.S. GAAP financial measures, as it is unable to predict with reasonable certainty items outside of its control, such as Significant Items, without unreasonable effort. To read the entire report including breakdown of regional results click here. Tweet |
|
|
|
|
|
|
|
|
|||||||||||||
